Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates

J Glob Antimicrob Resist. 2018 Mar:12:169-170. doi: 10.1016/j.jgar.2018.01.016. Epub 2018 Feb 22.

Authors

Paolo Gaibani¹, Simone Ambretti², Maria Vittoria Tamburini², Edoardo Vecchio Nepita², Maria Carla Re³

Affiliations

¹ Operative Unit of Clinical Microbiology, S. Orsola-Malpighi University Hospital, Bologna, Italy. Electronic address: [email protected].
² Operative Unit of Clinical Microbiology, S. Orsola-Malpighi University Hospital, Bologna, Italy.
³ Operative Unit of Clinical Microbiology, S. Orsola-Malpighi University Hospital, Bologna, Italy; University of Bologna, Bologna, Italy.

PMID: 29412181
DOI: 10.1016/j.jgar.2018.01.016

No abstract available

Publication types

Evaluation Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bacterial Typing Techniques / methods*
Humans
Klebsiella Infections / diagnosis
Klebsiella Infections / microbiology*
Klebsiella pneumoniae / chemistry
Klebsiella pneumoniae / enzymology
Klebsiella pneumoniae / isolation & purification*
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods
Tandem Mass Spectrometry / methods*
beta-Lactamases / chemistry*
beta-Lactamases / metabolism

Substances

beta-Lactamases
beta-lactamase KPC-2, Klebsiella pneumoniae